These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 21198665

  • 1. DNA vaccines: an historical perspective and view to the future.
    Liu MA.
    Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. DNA vaccines for cancer.
    Boyd D, Hung CF, Wu TC.
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [Abstract] [Full Text] [Related]

  • 4. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine.
    Kim JJ, Trivedi NN, Wilson DM, Mahalingam S, Morrison L, Tsai A, Chattergoon MA, Dang K, Patel M, Ahn L, Boyer JD, Chalian AA, Schoemaker H, Kieber-Emmons T, Agadjanyan MA, Weiner DB.
    Oncogene; 1998 Dec 17; 17(24):3125-35. PubMed ID: 9872328
    [Abstract] [Full Text] [Related]

  • 5. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H, Zhou C, Wang D, Ma W, Liang X, Lin C, Zhang Y, Zhang S.
    Immunol Lett; 2005 Jun 15; 99(1):85-93. PubMed ID: 15894116
    [Abstract] [Full Text] [Related]

  • 6. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M, Leder C, Pisa P.
    Expert Rev Vaccines; 2005 Jun 15; 4(3):315-27. PubMed ID: 16026247
    [Abstract] [Full Text] [Related]

  • 7. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 15; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM, Draghia-Akli R.
    Expert Rev Vaccines; 2008 Sep 15; 7(7):1085-101. PubMed ID: 18767956
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccines for the treatment of prostate cancer.
    Alam S, McNeel DG.
    Expert Rev Vaccines; 2010 Jul 15; 9(7):731-45. PubMed ID: 20624047
    [Abstract] [Full Text] [Related]

  • 10. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ, Weiner DB.
    Int Rev Immunol; 2006 Jul 15; 25(3-4):99-123. PubMed ID: 16818367
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 12. Current progress of DNA vaccine studies in humans.
    Lu S, Wang S, Grimes-Serrano JM.
    Expert Rev Vaccines; 2008 Mar 15; 7(2):175-91. PubMed ID: 18324888
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
    Marshall DJ, Rudnick KA, McCarthy SG, Mateo LR, Harris MC, McCauley C, Snyder LA.
    Vaccine; 2006 Jan 16; 24(3):244-53. PubMed ID: 16135392
    [Abstract] [Full Text] [Related]

  • 14. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA, Chang MC, Sun WZ, Chen YL, Chiang YC, Hsieh CY, Chen SM, Hsiao PN, Cheng WF.
    Gene Ther; 2009 Jun 16; 16(6):776-87. PubMed ID: 19357714
    [Abstract] [Full Text] [Related]

  • 15. Technologies for enhanced efficacy of DNA vaccines.
    Saade F, Petrovsky N.
    Expert Rev Vaccines; 2012 Feb 16; 11(2):189-209. PubMed ID: 22309668
    [Abstract] [Full Text] [Related]

  • 16. Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer.
    Lin CC, Yen MC, Lin CM, Huang SS, Yang HJ, Chow NH, Lai MD.
    J Gene Med; 2008 Jun 16; 10(6):679-89. PubMed ID: 18324638
    [Abstract] [Full Text] [Related]

  • 17. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K, Chang Y, Prud'homme GJ.
    Gene Ther; 2000 Mar 16; 7(6):481-92. PubMed ID: 10757021
    [Abstract] [Full Text] [Related]

  • 18. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M, Küpcü Z, Schüller S, Zalusky D, Zehetner M, Paster W, Schweighoffer T.
    Cancer Res; 2002 Oct 01; 62(19):5489-94. PubMed ID: 12359758
    [Abstract] [Full Text] [Related]

  • 19. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 01; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 20. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D.
    Immunol Rev; 2004 Jun 01; 199():156-80. PubMed ID: 15233733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.